v3.26.1
Interim Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Operating expenses        
Research and development $ 1,142 $ 1,287 $ 2,067 $ 3,780
General and administrative 1,099 975 2,024 1,969
Total operating expenses 2,241 2,262 4,091 5,749
Financing income, net 76 205 153 369
Loss before taxes 2,165 2,057 3,938 5,380
Taxes on income 0 0 0 0
Net loss for the period $ 2,165 $ 2,057 $ 3,938 $ 5,380
Basic loss per Ordinary Share [1] $ 0.003 $ 0.004 $ 0.006 $ 0.012
Diluted loss per Ordinary Share $ 0.003 $ 0.004 $ 0.006 $ 0.012
Weighted average number of Ordinary Shares outstanding, basic [1] 640,243,933 463,508,519 639,483,242 459,829,621
Weighted average number of Ordinary Shares outstanding, diluted 640,243,933 463,508,519 639,483,242 459,829,621
[1] 1 American Depositary Share (ADS) represents 80 Ordinary Shares